Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Revenue

Abeona Therapeutics had revenue of $3.50M in the twelve months ending March 31, 2024, with 227.72% growth year-over-year. In the year 2023, Abeona Therapeutics had annual revenue of $3.50M with 147.52% growth.

• Revenue (ttm): $3.50M
• Revenue Growth: +227.72%
• P/S Ratio: 59.81
• Revenue / Employee: $41,667
• Employees: 84
• Market Cap: 209.32M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.50M	2.09M	147.52%
Dec 31, 2022	1.41M	-1.59M	-52.87%
Dec 31, 2021	3.00M	-7.00M	-70.00%
Dec 31, 2020	10.00M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	3.00M	2.16M	258.18%
Dec 31, 2017	837.00K	-52.00K	-5.85%
Dec 31, 2016	889.00K	-151.00K	-14.52%
Dec 31, 2015	1.04M	115.00K	12.43%
Dec 31, 2014	925.00K	-1.12M	-54.70%
Dec 31, 2013	2.04M	-2.36M	-53.63%
Dec 31, 2012	4.40M	2.54M	135.63%
Dec 31, 2011	1.87M	1.34M	251.98%
Dec 31, 2010	531.00K	179.00K	50.85%
Dec 31, 2009	352.00K	61.00K	20.96%
Dec 31, 2008	291.00K	234.00K	410.53%
Dec 31, 2007	57.00K	-	-
Dec 31, 2006	0	-	-
Dec 31, 2005	0	-	-
Dec 31, 2004	0	-	-
Dec 31, 2003	0	-	-
Dec 31, 2002	1.15M	904.00K	372.02%
Dec 31, 2001	243.00K	136.00K	127.10%
Dec 31, 2000	107.00K	92.00K	613.33%
Dec 31, 1999	15.00K	-	-
Dec 31, 1998	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.